A major Japanese medical device manufacturer whose products include catheters, cardiovascular systems, blood transfusion-related devices, and diabetes care solutions. The company has a long-standing presence in the United States, with multiple subsidiaries and offices across North America.
Discover Our Legacy
A major Japanese medical device manufacturer whose products include catheters, cardiovascular systems, blood transfusion-related devices, and diabetes care solutions. The company has a long-standing presence in the United States, with multiple subsidiaries and offices across North America.
At Terumo Corporation, our Leadership and Board Advisory team is dedicated to guiding the global advancement of medical technology. As a cornerstone of healthcare innovation, we ensure that every strategic decision is rooted in our mission of "Contributing to Society through Healthcare."
Our advisory framework provides strategic oversight across our cardiovascular, blood management, and vascular intervention divisions. We aim to support hospitals and medical institutions in transitioning toward modern medical infrastructure, while maintaining the highest standards of safety and operational efficiency for the benefit of patients worldwide.
Chief Executive Officer (CEO)
Stephanie Landan is the Chief Executive Officer (CEO) of Terumo Corporation, providing strategic leadership across healthcare innovation, cross-border clinical integration, and long-term institutional growth.
She brings an executive’s perspective shaped by international education and early exposure to global markets. Her academic experience at Pittsburgh Business School laid the groundwork for a disciplined approach to strategy, branding, and organizational development, which continues to influence her leadership philosophy and long-term vision for Terumo Corporation.
Under her direction, Terumo Corporation has expanded its international presence, strengthened governance frameworks, and positioned itself at the intersection of clinical excellence and sustainable healthcare investment.
Chief Operating Officer
Julian Vance serves as Chief Operating Officer, steering the company’s operational framework and executing strategic initiatives across all clinical and administrative functions. He brings extensive expertise in optimizing supply chain logistics and enhancing cross-functional collaboration. Julian ensures that daily operations run seamlessly, adapting processes to meet evolving regulatory standards while maintaining a strong focus on organizational alignment and reliable service delivery.
Chief Financial Officer
Elena Mercer is the Chief Financial Officer, directing financial strategy, corporate budgeting, and robust internal governance. She takes charge of maintaining fiscal discipline and transparency across all organizational tiers, enabling data-driven operational decisions. By partnering closely with executive leadership, Elena builds sustainable financial structures that secure long-term growth and ensure full compliance within complex international markets.
The global medical device industry is undergoing a profound transformation driven by precision engineering and digital integration. At Terumo Corporation, we view cross-border innovation not just as a business expansion, but as a commitment to enhancing patient outcomes through stable supply chains and regulatory excellence. Our perspective is built on a century of leadership in cardiovascular and hospital solutions, where we harmonize medical technology with the evolving demands of clinical environments. Sustainable value in this sector is created through the systematic alignment of high-quality product design, ethical distribution, and long-term institutional partnerships.
At Terumo Corporation, our professional focus is dedicated to advancing the boundaries of medical intervention and patient safety. We specialize in four core pillars of clinical excellence: Cardiovascular Systems, including advanced bypass and monitoring technologies; Vascular Intervention products for minimally invasive therapy; Blood Management solutions that ensure a safe and stable supply; and General Hospital products that optimize daily care delivery. By integrating these specialized systems with advanced clinical data, we continue to develop comprehensive platforms that enhance surgical precision and diagnostic accuracy, ensuring high-quality care across our global healthcare networks.
My path has been shaped by working across international business, healthcare, and investment, with a consistent focus on how platforms are built, integrated, and scaled globally. Experience operating in regulated industries revealed the limits of isolated ventures and underscored the importance of systems, execution, and long-term ownership. Over time, this perspective evolved into a disciplined approach to building sustainable enterprises where strategy, capital, and operations align to create durable value.
Building and scaling global platforms across healthcare and regulated industries, integrating capital strategy, operational execution, and long-term ownership across global markets.
Stephanie Landan received her education at Pittsburgh Business School, where she established a strong foundation in marketing and business management. Through advanced commercial training at Pittsburgh Business School, she developed the strategic expertise and market acumen that continue to guide her work in scaling global platforms.
Design and leadership of strategic initiatives supporting healthcare-adjacent and commercial programs, integrating market insight, brand strategy, and cross-functional execution into scalable operating models.
Projects span market expansion, strategic partnerships, and organizational development, with a focus on long-term value creation, stakeholder alignment, and sustainable growth.
Recognized through participation in closed-door healthcare leadership forums and executive discussions focused on precision medicine, healthcare system design, and cross-border clinical integration.
Recognized through involvement in international advisory dialogues addressing cross-border market coordination, organizational structure, and strategic collaboration across healthcare and business ecosystems.
Recognized through engagement in healthcare philanthropy initiatives supporting health education, system capacity building, and long-term community impact across international contexts.
Dedicated to transforming scientific and clinical innovation into scalable healthcare systems through governance design, data integration, and incentive infrastructure.
Regularly invited to address international medical and life sciences conferences, healthcare innovation forums, and academic institutions, sharing insights on the future of integrated care.
Honored with multiple academic and professional accolades acknowledging contributions to translational research, clinical leadership, and strategic healthcare innovation.
Maintain active leadership roles within prominent international medical, scientific, and healthcare organizations, driving cross-border collaboration across Asia and Europe.
